Navigation Links
Cats' eye diseases genetically linked to diseases in humans
Date:3/4/2009

COLUMBIA, Mo. About one in 3,500 people are affected with retinitis pigmentosa (RP), a disease of the retina's visual cells that eventually leads to blindness. Now, a University of Missouri researcher has identified a genetic link between cats and humans for two different forms of RP. This discovery will help scientists develop gene-based therapies that will benefit both cats and humans.

"The same genetic mutations that cause retinal blindness in humans also cause retinal blindness in cats," said Kristina Narfstrom, the Ruth M. Kraeuchi-Missouri Professor in Veterinary Ophthalmology in the MU College of Veterinary Medicine. "Now, cats with these mutations can be used as important animal models to evaluate the efficiency of gene therapy. In addition, the eye is an ideal organ to use as we examine the potential of gene replacement intervention because it offers an accessible and confined environment."

Researchers examined the genetic mutations in two groups of cats; one with a congenital form of RP and another with a late-onset form and were able to identify the genes responsible for both forms of the disease in cats. In the study, researchers found that cats with the late-onset form of the disease have a mutation in the CEP290 gene, which is the same mutation found in humans with Joubert syndrome and Leber's congenital amaurosis. In both of these diseases, the genetic mutations result in changes in the function and structure of the photoreceptors. A photoreceptor is a nerve cell found in the eye's retina that is capable of phototransduction, or the process by which light is converted into electrical signals. The changes in the photoreceptors result in cell death, which lead to blindness.

"Cats are excellent models because they have relatively large eyes that are comparable to those of human babies. The retinal changes that occur and the progression to blindness in cats is similar to what happens in the human disease," Narfstrom said. "As a surgeon, I can use the same treatment methods and tools in cats that they use in humans."

Human autosomal recessive RP is among the most common cause of retinal degeneration and blindness, with no therapeutic intervention available. Initially it leads to night blindness, then loss of peripheral vision and, with progression, there is also a loss of central vision.

Like humans, Abyssinian cats with the CEP290 mutation have normal vision at birth but develop early changes in the interior of their eyes by the time they are approximately 2 years old. The cats with the congenital form of the disease are blind from birth with severe changes in the interior of their eyes after only a couple of months.


'/>"/>

Contact: Kelsey Jackson
JacksonKN@missouri.edu
573-882-8353
University of Missouri-Columbia
Source:Eurekalert  

Related biology news :

1. Choosing dry or wet food for cats makes little difference
2. The truth about cats and dogs
3. Dogs chase efficiently, but cats skulk counterintuitively
4. Big cats, wild pigs and short-eared dogs -- oh, my!
5. Clemson chemists discover new way antioxidants fight debilitating diseases
6. 60 second test could help early diagnosis of common brain diseases
7. U of MN researchers discover noninvasive diagnostic tool for brain diseases
8. U of Minnesota researchers discover noninvasive diagnostic tool for brain diseases
9. Social habits of cells may hold key to fighting diseases
10. Researchers develop liquid crystal pharmaceuticals to fight cancer and other diseases
11. Zebrafish to shed light on human mitochondrial diseases
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Cats' eye diseases genetically linked to diseases in humans
(Date:1/12/2017)...  Trovagene, Inc. (NASDAQ: TROV ), a ... that it has signed agreements with seven strategic partners ... Middle East for commercialization of the ... wave of international distribution agreements for Trovagene,s CLIA based ... The initial partners will introduce Trovagene,s liquid biopsy ...
(Date:1/11/2017)... -- Michael Johnson, co-founder of Visikol Inc. a company originally funded with ... to the elite "Forbes 30 Under 30" list in the Science ... 20 fields nationwide to be recognized as a leader in business ... ... a PhD candidate at Rutgers University. Visikol ...
(Date:1/4/2017)... thousands of attendees at this year,s International Consumer Electronics Show (CES), ... devices and services, will be featuring its new line of ULTRA CONNECT ... special CES Exhibit Suite , the new upper arm and wrist smart ... product platform.  Continue Reading ... ...
Breaking Biology News(10 mins):
(Date:1/11/2017)... ... January 11, 2017 , ... ... Research show early promise of the investigational anti-cancer agent tucatinib (formerly ONT-380) against ... previous treatment regimens. Twenty-seven percent of these heavily pretreated patients saw clinical benefit ...
(Date:1/11/2017)... , ... January 11, 2017 , ... ... year and costing healthcare systems more than $23.7 billion, healthcare systems are ... , Among the most common sepsis-causing pathogens are bacteria and the yeast ...
(Date:1/11/2017)... ... 11, 2017 , ... Symbios Technologies, Inc., a ... Science Foundation (NSF) has awarded Symbios a Small Business Innovation Research (SBIR) ... the Symbios Tubular Plasma Reactor™ (TPR™) by scaling the system for first customer ...
(Date:1/11/2017)... 11, 2017  GenVec, Inc. (NASDAQ: ... today that its chief scientific officer, Douglas ...  "AdenoVerse™ platform for translational development of innovative gene ... the upcoming Phacilitate Cell & Gene Therapy World ... Florida.  Dr. Brough,s presentation will highlight the utility ...
Breaking Biology Technology: